Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant
- 22 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 68 (1), 203-209
- https://doi.org/10.1007/s12020-020-02209-4
Abstract
Purpose Recent guidelines on adrenal incidentalomas suggested in patients with an indeterminate adrenal mass and no significant hormone excess that follow up with a repeat noncontrast CT or MRI after 6–12 months may be an option. Methods We report the case of a 32-year-old woman who presented with a 2.9 × 1.9 cm left adrenal incidentaloma that was stable in size for 4 years. Ten years later the left adrenal mass was a stage IV adrenocortical carcinoma (ACC). Results In 2006, a 32-year-old French Canadian woman was referred to endocrinology for a left 2.9 × 1.9 cm incidentally discovered adrenal mass (31 HU). She had normal hormonal investigation. The patient was followed with adrenal imaging and hormonal investigation yearly for 4 years and the lesion stayed stable in size over the 4 years. Ten years later, in 2016, the patient presented with renal colic. Urological CT unexpectedly revealed that the left adrenal mass was now measuring 9 × 8.2 cm and 2 new hepatic lesions were found. Biochemical workup demonstrated hypercorticism and hyperandrogenemia: plasma cortisol after 1 mg overnight DST of 476 nmol/L and DHEA-S of 14.0 μmol/L (N 0.9–6.5). Twenty-four hour urine steroid profiling was consistent with an adrenocortical carcinoma (ACC) co-secreting cortisol, androgens and glucocorticoid precursors. The diagnosis of ACC with hepatic ACC metastases was confirmed at histology. Following genetic analysis, germline heterozygous variant of uncertain significance (VUS) was identified in the exon 16 of the APC gene (c.2414G > A, p.Arg805Gln). Immunohistochemical staining’s of the ACC was positive for IGF-2 and cytoplasmic/nuclear β-catenin staining. Conclusions This case illustrates that (1) small adrenal incidentaloma stable in size may evolve to ACC and (2) better genetic characterization of these patients may eventually give clues on this unusual evolution.Funding Information
- Fonds de Recherche du Québec - Santé
This publication has 22 references indexed in Scilit:
- High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal DisordersClinical Chemistry, 2017
- Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal TumorsActa Endocrinologica, 2016
- UMD‐Predictor: A High‐Throughput Sequencing Compliant System for Pathogenicity Prediction of any Human cDNA SubstitutionHuman Mutation, 2016
- Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical CancerHormones and Cancer, 2015
- PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indelsBioinformatics, 2015
- MutationTaster2: mutation prediction for the deep-sequencing ageNature Methods, 2014
- PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related MutationsPLoS Computational Biology, 2014
- A novel indel in exon 9 of APC upregulates a ‘skip exon 9’ isoform and causes very severe familial adenomatous polyposisEuropean Journal of Human Genetics, 2013
- Transcript dosage effect in familial adenomatous polyposis: Model offered by two kindreds with exon 9APC gene mutationsHuman Mutation, 1998
- APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposisHuman Genetics, 1995